Kristine Freude has received a grant from the Novo Nordisk Foundation for her project: “Investigation of Microglia in Sporadic Alzheimer’s Disease as Proinflammatory Drivers in Patient Derived Cell Models (GliAD).” Her team is researching a hereditary form of dementia which affects the brain’s frontal lobes. People with this unique type of dementia start to see the effects of the disease in their 50s – much earlier than other forms of dementia. For the study, Freude is using DNA from a family in West Jutland who have this form of dementia. The long-term goal for the research project is to develop a cure or at least slow down the development of the dementia.
>> Learn more about the research project on Politiken
>> Check out Kristine Freude’s DIS course, Epigenetics and the EnvironmentBack to all news